Celgene Corp. (CELG)

89.26
0.22 0.25
NASDAQ : Health Technology
Prev Close 89.48
Open 90.03
Day Low/High 88.90 / 91.05
52 Wk Low/High 84.25 / 147.17
Volume 2.44M
Avg Volume 7.39M
Exchange NASDAQ
Shares Outstanding 752.18M
Market Cap 66.91B
EPS 3.80
P/E Ratio 24.44
Div & Yield N.A. (N.A)

Latest News

Watch Oncology Stocks Ahead of 2 Big Events

Watch Oncology Stocks Ahead of 2 Big Events

Data and industry conferences will likely be catalysts for shares in the space.

U.S. Senator Cory Booker Criticizes Pharma Companies in New Tax Report

U.S. Senator Cory Booker Criticizes Pharma Companies in New Tax Report

The Trump Administration cut corporate taxes and U.S. Senator Cory Booker hoped pharma companies would cut drug prices. That didn't happen and Booker's new analysis hammers those drug companies.

3 Potential Biotech Buyout Targets in the Second Quarter

3 Potential Biotech Buyout Targets in the Second Quarter

Novartis' deal for AveXis has ignited a rally in other gene-therapy concerns.

Getting Ready for Biotech Earnings

Getting Ready for Biotech Earnings

Now that M&A is picking up in the sector, here's what to watch as earnings releases begin to hit.

Possible Biotech Takeout Plays

Possible Biotech Takeout Plays

A look at possible second-quarter M&A activity in the biotech sector.

CELG INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Celgene Corporation

CELG INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Celgene Corporation

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Celgene Corporation ("Celgene" or the "Company") (NASDAQGS: CELG) violated federal securities laws.

Chart of the Day: Celgene

CELG finally may be ready to turn.

Sentiment Shifts in Real Time

You could sense the change in sentiment as the day progressed.

CELG SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Celgene Corporation

CELG SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Celgene Corporation

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Celgene Corporation ("Celgene" or the "Company") (NASDAQGS:CELG) violated federal securities laws.

Why Uber's Self-Driving Car Fatality Won't End Autonomous Driving

Why Uber's Self-Driving Car Fatality Won't End Autonomous Driving

The fatality that came at the hands of a self-driving Uber vehicle was tragic. But keep in mind, self-driving cars will be safer than human drivers in the not-too-distant future.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Celgene Corporation

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Celgene Corporation

Levi & Korsinsky announces it has commenced an investigation of Celgene Corporation ("Celgene" or "the Company") (NASDAQGS: CELG) concerning possible violations of federal securities laws.

Celgene Corporation Announces Departure Of President And Chief Operating Officer Scott A. Smith

Celgene Corporation Announces Departure Of President And Chief Operating Officer Scott A. Smith

Celgene Corporation (NASDAQ: CELG) today announced that Scott A. Smith, President and Chief Operating Officer, is leaving the company effective immediately.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Celgene Corporation

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Celgene Corporation

Levi & Korsinsky announces it has commenced an investigation of Celgene Corporation ("Celgene" or "the Company") (NASDAQGS:CELG) concerning possible violations of federal securities laws.

Celgene Shares Higher on Co-Development Pact With Bluebird

Celgene Shares Higher on Co-Development Pact With Bluebird

The biotech firms will work to develop and promote a potential treatment for relapsed and refractory multiple myeloma.

Celgene Showing a Bullish Divergence But Is Still In a Downtrend

Celgene Showing a Bullish Divergence But Is Still In a Downtrend

Let's check the charts.

New Opportunities in Biotech: Cramer's 'Off the Charts'

New Opportunities in Biotech: Cramer's 'Off the Charts'

The beaten down biotech sector may offer more opportunities in this newly volatile market environment.

Chopping a Way Back for the Bull: Cramer's 'Mad Money' Recap (Tuesday 3/21/18)

Chopping a Way Back for the Bull: Cramer's 'Mad Money' Recap (Tuesday 3/21/18)

Jim Cramer maps out what investors need to find a way back to the upside, including the Fed, interest rates and earnings.

Which Hot Biotech Name Will Be Acquired Next?

Which Hot Biotech Name Will Be Acquired Next?

Your burning biotech questions answered in our latest mailbag.

Bret Jensen's Biotech Mailbag

Bret Jensen's Biotech Mailbag

We'll answer two of the common questions we have received so far in March.

Celgene Completes Acquisition Of Juno Therapeutics, Inc., Advancing Global Leadership In Cellular Immunotherapy

Celgene Completes Acquisition Of Juno Therapeutics, Inc., Advancing Global Leadership In Cellular Immunotherapy

Celgene Corporation (NASDAQ:CELG) today announced that it has completed the acquisition of Juno Therapeutics, Inc.

TheStreet Quant Rating: C (Hold)